SMFM’s 41st Annual Pregnancy Meeting: Part 1

Check out the top conferences happening in the second quarter of 2025.

Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.

Sexual inactivity worsens SSRI side effects in women, but gepirone-ER shows fewer impacts.

Research suggests that hormone replacement therapy, especially with testosterone, may help alleviate mood symptoms in menopausal women and reduce the need for antidepressants.

A new study presented at ISSWSH highlights patient dissatisfaction with current treatments for recurrent bacterial vaginosis, emphasizing the need for more effective therapies and improved provider communication.

While pain is a common deterrent for patients considering an IUD, there are no standardized guidelines for pain relief during insertion or removal.